Refine
Year of publication
Document Type
- Article (439) (remove)
Institute
- Wirtschaft (133)
- Forschungszentrum Mikrotechnik (96)
- Forschungszentrum Business Informatics (67)
- Technik | Engineering & Technology (55)
- Department of Computer Science (Ende 2021 aufgelöst; Integration in die übergeordnete OE Technik) (54)
- Forschungszentrum Energie (51)
- Soziales & Gesundheit (49)
- Forschungsgruppe Empirische Sozialwissenschaften (22)
- Didaktik (mit 31.03.2021 aufgelöst; Integration ins TELL Center) (20)
- Josef Ressel Zentrum für Materialbearbeitung (15)
Language
- English (279)
- German (158)
- Multiple languages (2)
Is part of the Bibliography
- yes (439) (remove)
Keywords
- Laser ablation (8)
- Entscheidung (6)
- Evolution strategy (5)
- Soziale Arbeit (5)
- Volatile organic compounds (5)
- Y-branch splitter (5)
- Ausscheidung (4)
- Demand side management (4)
- Organisation (4)
- Schreibdidaktik (4)
Adult muscle carnitine palmitoyltransferase (CPT) II deficiency is a rare autosomal recessive disorder of long-chain fatty acid metabolism. It is typically associated with recurrent episodes of exercise-induced rhabdomyolysis and myoglobinuria, in most cases caused by a c.338C > T mutation in the CPT2 gene. Here we present the pedigree of one of the largest family studies of CPT II deficiency caused by the c.338C > T mutation, documented so far. The pedigree comprises 24 blood relatives
of the index patient, a 32 year old female with genetically proven CPT II deficiency. In total, the mutation was detected in 20 family members, among them five homozygotes and 15 heterozygotes. Among all homozygotes, first symptoms of CPT II deficiency occurred during childhood. Additionally, two already deceased relatives of the index patient were carriers of at least one copy of the genetic variant, revealing a remarkably high prevalence of the c.338C > T mutation within the tested family. Beside the index patient, only one individual had been diagnosed with CPT II deficiency prior to this study and three cases of CPT II deficiency were newly detected by this family study, pointing
to a general underdiagnosis of the disease. Therefore, this study emphasizes the need to raise awareness of CPT II deficiency for correct diagnosis and accurate management of the disease.
Pooled data from published reports on infants with clinically diagnosed vitamin B12 (B12) deficiency were analyzed with the purpose of describing the presentation, diagnostic approaches, and risk factors for the condition to inform prevention strategies. An electronic (PubMed database) and manual literature search following the PRISMA approach was conducted (preregistration with the Open Science Framework, accessed on 15 February 2023). Data were described and analyzed using correlation analyses, Chi-square tests, ANOVAs, and regression analyses, and 102 publications (292 cases) were analyzed. The mean age at first symptoms (anemia, various neurological symptoms) was four months; the mean time to diagnosis was 2.6 months. Maternal B12 at diagnosis, exclusive breastfeeding, and a maternal diet low in B12 predicted infant B12, methylmalonic acid, and total homocysteine. Infant B12 deficiency is still not easily diagnosed. Methylmalonic acid and total homocysteine are useful diagnostic parameters in addition to B12 levels. Since maternal B12 status predicts infant B12 status, it would probably be advantageous to target women in early pregnancy or even preconceptionally to prevent infant B12 deficiency, rather than to rely on newborn screening that often does not reliably identify high-risk children.
Das CIRCU
(2016)
Kernfähigkeiten des Dialogs
(2012)
Brainstorming ist ein Mythos
(2021)
Ethikorientiert entscheiden
(2021)